# Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF

> **NCT01946399** · NA · TERMINATED · sponsor: **Retina Research Institute, LLC** · enrollment: 10 (actual)

## Conditions studied

- Retinal Vein Occlusion (RVO)
- Macular Edema

## Interventions

- **DRUG:** Ozurdex implant

## Key facts

- **NCT ID:** NCT01946399
- **Lead sponsor:** Retina Research Institute, LLC
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09
- **Primary completion:** 2016-09-01
- **Final completion:** 2017-09-01
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** enrollment not met
- **Last updated:** 2017-12-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01946399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01946399, "Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01946399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*